Odisha

Odisha Govt Forms Expert Panel On Use Of New Drugs For COVID-19 Treatment

By
OB Bureau

Bhubaneswar: The Odisha government has constituted an expert committee for taking decision on the use of Tocilizumab and other new drugs for treatment of COVID-19 patients.

In a letter to district collectors, municipal commissioners, CDMOs and superintendents of medical colleges in the state, additional chief secretary, Health and Family Welfare department PK Mohapatra said as the number of COVID cases is increasing day by day in the second wave of the pandemic, the government is keen on providing the appropriate treatment to the patients to reduce the mortality as well as morbidity.

There are certain drugs available for COVID management which have restricted availability and also there are many newer drugs coming up with uncertain efficacy. Many physicians and critical care specialists sometimes recommend those.

In view of’ the above, an expert committee has been constituted to examine and assess the proposal of use of such drugs on case to case basis under the supervision Of DMET.

The committee will have Dr Bidyut Das, Professor, Rheumatology, SCB MCH Cuttack as chairman and Dr Jyoti Patnaik, Professor Pulmonary Medicine, SCB MCH and Dr PK Thatoi, Associate Professor, Medicine, SCB MCH will be members.

The committee has been assigned the following responsibilities:

1. When any prescription is made for a Covid patient in a Covid facility with such newer and restricted available drug, the prescription shall come as a proposal to seek opinion regarding the judicious use of the drug. Such proposal shall be sent to the Chairman of the Committee with an intimation to DMET, Odisha and MD OSMCL.

2, The requisition will be accompanied by following documents:
a. ID proof
b. Prescription of the treating doctor
c. Case sheet along with the investigations done

3. The committee will examine the records and certify the efficacy of the drug as well as the judiciousness in use in the particular case. If considered for use. the recommendation shall be made to MD OSMCL.

4. After obtaining such recommendation, OSMCL will issue the drug as per
the availability

OB Bureau

Recent Posts

India Makes Formal Bid To Host 2036 Olympics, Sends Letter Of Intent To IOC: Reports

New Delhi: India has taken the first step in its attempt to host the 2036…

November 5, 2024

Bullets Fired At Nandan Kanan Express Train In Odisha’s Bhadrak! Probe Launched

Bhadrak: Amid allegations that bullets were fired at the Nandan Kanan Express train near Charampa…

November 5, 2024

Odisha Health Dept Official Arrested For Carrying Rs 2.8 Lakh ‘Ill-Gotten’ Cash

Bhubaneswar: Odisha Vigilance on Tuesday arrested senior assistant in Additional District Public Health Office (Family…

November 5, 2024

Rain May Lash Bhubaneswar & 4 Odisha Dists By 6PM Today; Dry Spell From Nov 8

Bhubaneswar: The regional centre of India Meteorological Department (IMD) has sounded yellow warning for four…

November 5, 2024

Odisha Deputy CM Holds Talks With Indian Envoy In London On Measures To Boost Tourism

Bhubaneswar: Odisha’s Deputy Chief Minister Pravati Parida held a meeting with the Indian High Commissioner…

November 5, 2024

India To Celebrate 125th Birth Anniv Of Odisha’s First CM Harekrushna Mahatab, Informs Mohan Majhi

Bhubaneswar: Chief Minister Mohan Charan Majhi on Tuesday informed about the central government's plans for…

November 5, 2024

Cracks On Puri Jagannath Temple’s Meghanada Pacheri: Odisha BJP Blames Previous BJD Govt

Bhubaneswar: Amid a brouhaha over cracks detected on the ‘Meghanada Pacheri’ surrounding Shree Jatannath Temple…

November 5, 2024

Daughter’s Name Can’t Be Deleted From List Of Family Members Eligible For Govt Employee’s Pension

New Delhi: In a recently released guidelines, the Department of Pension and Pensioners’ Welfare (DoPPW)…

November 5, 2024